People Spotlight: Bryan Minihan, Health Decisions Chief Technology Officer
By Cameron Snipes
July 30, 2010 - Armed with 15 years of technology experience, Bryan Minihan has been tapped to lead the technology function of clinical research firm Health Decisions.
With experience at companies such as GlaxoSmithKline and Accenture, Minihan is charged with implementing Health Decisions’ proprietary HD360º technology platform.
Health Decisions bills the platform as the technological backbone responsible for the collection, assembly and integration of information gathered in the clinical trials process.
Rick Farris, Health Decisions’ chief operating officer, sums up Minihan’s responsibilities succinctly.
“Under his guidance, HD360° will empower our sponsors and study teams with immediate insight into the progress of their studies, allowing early detection and correction of emerging issues before they threaten budget and timeline,” he said in a statement. “HD360° will also reveal opportunities to reallocate monitoring resources or otherwise improve efficiency.”
It’s about “immediate access to the most accurate, actionable information to make clinical studies safer and more efficient than has previously been possible,” Minihan said in a statement.
Founded in 1990, Health Decisions is a clinical research organization that works with various biotechnology and pharmaceutical companies to conduct Phase I-IV trials, global registration studies and multiple 510(k)s and pre-market approval studies. The trials cover myriad therapy areas, including neurology, renal, oncology, and women’s health issues.
Health Decisions is based in Durham and is helmed by its founder, Dr. Michael Rosenberg.
BACKGROUND
Minihan has 15 years of information technology and information systems experience. Over the course of his career, he has specialized in agile and traditional project management, usability and interface design, web application development, network engineering and software architecture.
Since beginning his career, Minihan has built several IT teams, serving as CTO for three Internet startup companies.
Minihan also directed GlaxoSmithKline’s global intranet usability and web analytics teams and drove the development of projects and products for Accenture, Intuit and Cisco.
GOAL
“I’m excited to be a part of (Health Decisions’) agile clinical development and its mission to fulfill the most basic need of the drug development industry,” Minihan says.